You are here

Co-infections

Hepatitis C in EECA

Hepatitis C in Eastern Europe and Central Asia. Civil Society Response to the Epidemic

by
Alliance for Public Health

The purpose of this report is to provide an overview of key aspects of the hepatitis C (HCV) epidemic and response in Eastern Europe and Central Asia (EECA). It also outlines tools and activities for civil society organizations (CSOs) and community-based groups working on expanding access to HCV...

Tags: General public, NGOs, People living with HIV (PLHIV), People who use drugs (PUD), Central Asia, Eastern Europe, Advocacy, Affordability, Co-infections, Epidemiology, Inequalities in health, Laws and regulations, Legislation, Monitoring and Evaluation, Policy, Viral hepatitis
Read more
Hepatitis C among drug users in Europe

Hepatitis C among drug users in Europe: epidemiology, treatment and prevention

by
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely contribution to raising awareness of the hepatitis C epidemic in Europe and the opportunities now opening up to tackle this problem decisively. A state of the art review of the epidemiology of...

Tags: Injecting drug users (IDUs), People who use drugs (PUD), WHO European region, Affordability, Co-infections, Harm reduction, Monitoring and Evaluation, Policy, Viral hepatitis
Read more
It's good to know

It's Good To Know

by
Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT)

This leaflet is the part of  Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT). 

Leaflets and posters for people who use drugs (PWUD) have been prepared by the Work package 4 “Testing and linkage to care” to promote rapid HIV and HCV tests in low threshold...

Tags: Injecting drug users (IDUs), People who use drugs (PUD), WHO European region, Co-infections, Harm reduction, Inequalities in health, Social issues, Testing and counselling
Read more

Bridging the Gaps: Health and rights of key populations: engaging underserved key population in Kyrgyztan: what works?

by
Dinara Magdybaeva, Aida Karipova, David Yanchinov

Within the framework of the programme “Bridging the Gaps: Health and rights of key populations”, operational research was conducted among people who inject drugs (PWID), sex workers (SW) and lesbian, gay, bisexual and transgender (LGBT) people, as well as outreach workers and managers of local...

Tags: Gay men and other MSM, Injecting drug users (IDUs), LGBTI, Men having sex with men (MSM), People living with HIV (PLHIV), People who are/were in prisons, People who use drugs (PUD), Prisoners (ex-), Sex workers, Women, Youth, Central Asia, Advocacy, Affordability, Care and support, Co-infections, Inequalities in health, Monitoring and Evaluation, Research, Resource mobilisation, STI's, Stigma and discrimination, Testing and counselling, Treatment, Treatment as prevention (TasP), Viral hepatitis
Read more
WHO Transgender people and HIV

Transgender people and HIV. Policy brief

by
World Healith Organization

This technical brief summarizes essential information and existing WHO recommendations for HIV prevention, diagnosis, treatment and care among transgender populations.

Tags: LGBTI, People living with HIV (PLHIV), Sex workers, Global, Care and support, Co-infections, Epidemiology, Gender, Harm reduction, Human rights, Pre-exposure prophylaxis (PrEP), Prevention, Reproductive health, Sexual and reproductive health, Stigma and discrimination, Testing and counselling, Treatment, Tubercolosis, Viral hepatitis
Read more

HA-REACT: Joint Action on HIV and Co-Infection Prevention and Harm Reduction

The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID). This three-year project was launched in late 2015...

Twitter News